Published by Abigail Townsend on 2nd June 2026
(Sharecast News) - Shares in Abivax tanked on Tuesday, after trial results for an inflammatory bowel drug developed by the French biotech disappointed.
URL: http://www.digitallook.com/dl/news/story/35971871/...